Product Description: Daclavir (Daclatasvir) is one of the new direct-acting antiviral drugs that target different steps of the hepatitis C virus (HCV) lifecycle. It is the first-ever approved HCV NS5A replication complex inhibitor, meaning it interferes with a protein the virus uses to reproduce.
Product Features:
| Product Name | : | Daclavir |
| Generic Name | : | Daclatasvir |
| Formulation | : | Tablet |
| Available Pack Size | : | 1×10’s |
| Available Strength | : | 60 mg |
| Registrations | : | Bangladesh |
